Title:
異なるタイプの細胞に機能的に影響を及ぼし、免疫性疾患、炎症性疾患、神経疾患、およびその他の疾患を治療するための新規なジペプチジルペプチダーゼIV阻害剤
Document Type and Number:
Japanese Patent JP2008500270
Kind Code:
A
Abstract:
The present invention relates to substances capable of specifically inhibiting Gly-Pro-p-nitroanilide cleaving peptidases, for a use in the medical field. Furthermore, the invention relates to the use of at least one of such substances or of at least one pharmaceutical or cosmetic composition containing at least one such substance for a prophylaxis or a therapy of diseases, particularly for a prophylaxis and a therapy of diseases accompanied by an excessive immune response (autoimmune diseases, allergies, transplant rejections), of other chronic-inflammatory diseases, of neuronal diseases and cerebral damage, of skin diseases (inter alia acne, psoriasis), of tumor diseases and of specific virus infections (inter alia SARS).
More Like This:
Inventors:
Anzolge, Siegfried
Bank, Ute
Nordhof, Karsten
Michael Tagger
Frank Strigow
Bank, Ute
Nordhof, Karsten
Michael Tagger
Frank Strigow
Application Number:
JP2006534708A
Publication Date:
January 10, 2008
Filing Date:
October 15, 2004
Export Citation:
Assignee:
IM GM Behr
Key Neurotech Pharmaceuticals AG
Key Neurotech Pharmaceuticals AG
International Classes:
C07D205/08; A61K31/16; A61K31/166; A61K31/167; A61K31/222; A61K31/265; A61K31/27; A61K31/395; A61K31/397; A61K31/427; A61K31/5377; A61K31/55; A61K31/551; A61P1/04; A61P11/06; A61P25/00; A61P29/00; A61P37/02; A61P43/00; C07C229/34; C07C235/56; C07C243/28; C07C251/56; C07C251/80; C07C251/86; C07C255/61; C07C259/14; C07C271/28; C07C311/08; C07C311/19; C07C311/29; C07C323/60; C07C327/48; C07D207/12; C07D207/277; C07D207/325; C07D209/08; C07D209/14; C07D209/40; C07D209/56; C07D209/86; C07D211/60; C07D211/88; C07D211/98; C07D213/74; C07D213/82; C07D213/84; C07D213/89; C07D217/02; C07D217/22; C07D217/24; C07D219/02; C07D221/14; C07D225/02; C07D231/14; C07D231/38; C07D233/88; C07D237/20; C07D241/52; C07D243/38; C07D257/04; C07D263/04; C07D271/08; C07D277/20; C07D277/34; C07D277/46; C07D277/82; C07D279/12; C07D295/12; C07D295/14; C07D295/18; C07D295/22; C07D307/46; C07D307/52; C07D307/54; C07D307/68; C07D307/80; C07D307/91; C07D311/04; C07D311/12; C07D317/30; C07D333/24; C07D333/34; C07D333/66; C07D333/68; C07D333/78; C07D333/80; C07D401/08; C07D401/12; C07D403/12; C07D405/12; C07D413/04; C07D413/14; C07D417/12; C07D471/04; C07D471/06; C07D473/08; C07D487/04; C07D487/06; C07D487/08; C07D491/052; C07D493/04; C07D495/04; C07D495/14; C07D495/22; C07D498/04; C07D513/04; C07D513/14; C07D519/00; C07F9/6506
Domestic Patent References:
| JP2007508349A | 2007-04-05 | |||
| JP2007508350A | 2007-04-05 | |||
| JP2000505063A | 2000-04-25 | |||
| JPS545996A | 1979-01-17 | |||
| JPH08157363A | 1996-06-18 | |||
| JPH1135494A | 1999-02-09 | |||
| JPS505533A | 1975-01-21 |
Foreign References:
| WO2003057200A2 | 2003-07-17 | |||
| WO2003068757A1 | 2003-08-21 | |||
| WO2001036426A1 | 2001-05-25 |
Attorney, Agent or Firm:
Hiromichi Nanjo